Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 3
1989 2
1990 1
1995 2
1996 2
1997 2
1998 2
1999 3
2000 1
2001 3
2002 3
2004 5
2005 2
2006 3
2007 5
2008 6
2009 8
2010 13
2011 14
2012 10
2013 13
2014 13
2015 5
2016 4
2017 3
2018 3
2019 6
2020 3
2021 5
2022 4
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Chalasani N, Li YJ, Dellinger A, Navarro V, Bonkovsky H, Fontana RJ, Gu J, Barnhart H, Phillips E, Lammert C, Schwantes-An TH, Nicoletti P, Kleiner DE, Hoofnagle JH; Drug Induced Liver Injury Network. Chalasani N, et al. Among authors: dellinger a. J Hepatol. 2023 Feb;78(2):293-300. doi: 10.1016/j.jhep.2022.09.010. Epub 2022 Sep 22. J Hepatol. 2023. PMID: 36152763 Free PMC article.
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate.
Nicoletti P, Dellinger A, Li YJ, Barnhart HX, Chalasani N, Fontana RJ, Odin JA, Serrano J, Stolz A, Etheridge AS, Innocenti F, Govaere O, Grove JI, Stephens C, Aithal GP, Andrade RJ, Bjornsson ES, Daly AK, Lucena MI, Watkins PB; Drug-Induced Liver Injury Network (DILIN); International Drug-Induced Liver Injury Consortium (iDILIC); Prospective European Drug-Induced Liver Injury (Pro-Euro DILI) Investigators. Nicoletti P, et al. Among authors: dellinger a. Gastroenterology. 2023 Mar;164(3):454-466. doi: 10.1053/j.gastro.2022.11.036. Epub 2022 Dec 7. Gastroenterology. 2023. PMID: 36496055 Free PMC article.
Pollen as the link between floral phenotype and fitness.
Opedal ØH, Pérez-Barrales R, Brito VLG, Muchhala N, Capó M, Dellinger A. Opedal ØH, et al. Among authors: dellinger a. Am J Bot. 2023 Jun;110(6):e16200. doi: 10.1002/ajb2.16200. Epub 2023 Jun 21. Am J Bot. 2023. PMID: 37345378
Application of fullerenes in nanomedicine: an update.
Dellinger A, Zhou Z, Connor J, Madhankumar AB, Pamujula S, Sayes CM, Kepley CL. Dellinger A, et al. Nanomedicine (Lond). 2013 Jul;8(7):1191-208. doi: 10.2217/nnm.13.99. Nanomedicine (Lond). 2013. PMID: 23837857 Review.
Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
Fereydouni M, Ahani E, Desai P, Motaghed M, Dellinger A, Metcalfe DD, Yin Y, Lee SH, Kafri T, Bhatt AP, Dellinger K, Kepley CL. Fereydouni M, et al. Among authors: dellinger a. Front Oncol. 2022 Apr 22;12:871390. doi: 10.3389/fonc.2022.871390. eCollection 2022. Front Oncol. 2022. PMID: 35574362 Free PMC article.
A novel class of compounds with cutaneous wound healing properties.
Zhou Z, Joslin S, Dellinger A, Ehrich M, Brooks B, Ren Q, Rodeck U, Lenk R, Kepley CL. Zhou Z, et al. Among authors: dellinger a. J Biomed Nanotechnol. 2010 Oct;6(5):605-11. doi: 10.1166/jbn.2010.1157. J Biomed Nanotechnol. 2010. PMID: 21329053
147 results